Nationwide surveillance of parenteral antibiotics containing meropenem activities against clinically isolated strains in 2002

Japanese Journal of Antibiotics

Volumn 57, Issue 1, 2004, Pages 70-104

  Yamaguchi, Keizo ^a   Ismi, Yoshikazu ^a   Iwata, Morihiro ^b   Watanabe, Naoki ^c   Uehara, Nobuyuki ^c   Yasujima, Minoru ^d   Kasai, Takeshi ^d   Suwabe, Akira ^e   Obata, Ritsuko ^e   Kaku, Mitsuo ^f   Kanemitsu, Keiji ^f   Yoshida, Hiroshi ^g   Satoh, Toshio ^g   Murakami, Masami ^h   Takahashi, Ayako ⁱ   Itoh, Kouichi ^j   Shibuya, Yasuhiro ^j   Kanno, Harushegi ^k   Kubo, Setsuko ^k   Maesaki, Shigefumi ^l   Hashikita, Giichi ^l   Igari, Jun ^m   Oguri, Toyoko ⁿ   Okada, Jun ^o   Tazawa, Yoko ^p   Nakashima, Hideki ^q   Takemura, Hiromu ^p   Horii, Toshinobu ^q   Baba, Hisashi ^r   Ishigo, Shiomi ^s   Fujita, Naohisa ^t   Komori, Tosiiiaki ^t   Ichiyama, Satoshi ^u   Maeda, Shigetaka ^u   Yamanaka, Kiyoharu ^v   Murata, Yoko ^v   Aihara, Masanori ^w   Kinoshita, Shohiro ^x   Taminato, Tomohiko ^y   Negayama, Kiyoshi ^y   Murase, Mitsuharu ^z   Miyamoto, Hitoshi ^z   Kusano, Nobuuchika ^aa   Mihara, Eiichirou ^aa   Kambe, Masayum ^ab   Itaha, Hideyuki ^ab   Ono, Junko ^ac   Yoshimura, Hisae ^ac   Hirakata, Yoichi ^ad   Matsuda, Junichi ^ad   Saikawa, Tetsunori ^ae   Hiramatsu, Kazufumi ^ae   more..

^a TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOHO UNIVERSITY OMORI MEDICAL CENTER   (Japan)

^c SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d HIROSAKI UNIVERSITY   (Japan)

^e IWATE MEDICAL UNIVERSITY   (Japan)

^f TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^g FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^h GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

ⁱ GUNMA UNIVERSITY HOSPITAL   (Japan)

^j JICHI MEDICAL UNIVERSITY   (Japan)

^k CHIBA UNIVERSITY HOSPITAL   (Japan)

^l SAITAMA MEDICAL UNIVERSITY   (Japan)

^m JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

ⁿ JUNTENDO UNIVERSITY HOSPITAL   (Japan)

^o Kanto Medical Center   (Japan)

^p ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^q HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^r NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^s OGAKI MUNICIPAL HOSPITAL   (Japan)

^t KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^u KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^v Ohtemae Hospital   (Japan)

^w TENRI HOSPITAL   (Japan)

^x KOBE UNIVERSITY HOSPITAL   (Japan)

^y KAGAWA UNIVERSITY   (Japan)

^z EHIME UNIVERSITY HOSPITAL   (Japan)

^aa OKAYAMA UNIVERSITY   (Japan)

^ab HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

^ac FUKUOKA UNIVERSITY HOSPITAL   (Japan)

^ad NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^ae OITA UNIVERSITY   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; AZTREONAM; BETA LACTAMASE INHIBITOR; CARBAPENEM DERIVATIVE; CEFACLOR; CEFAZOLIN; CEFEPIME; CEFMETAZOLE; CEFOTAXIME; CEFOTIAM; CEFOZOPRAN; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; CLINDAMYCIN; FLOMOXEF; GENTAMICIN; HABEKACIN; IMIPENEM; MEROPENEM; OXACILLIN; PENICILLIN G; PIPERACILLIN; SULPERAZON; SULTAMICILLIN; TEICOPLANIN; TOBRAMYCIN; UNINDEXED DRUG; VANCOMYCIN;

ANAEROBIC BACTERIUM; ANTIBACTERIAL ACTIVITY; BACTERIAL STRAIN; CROSS RESISTANCE; DRUG SURVEILLANCE PROGRAM; ENTEROBACTERIACEAE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HAEMOPHILUS INFLUENZAE; KLEBSIELLA PNEUMONIAE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PSEUDOMONAS AERUGINOSA; REVIEW; STAPHYLOCOCCUS EPIDERMIDIS;

BACTERIA; BACTERIAL INFECTIONS; CARBAPENEMS; DRUG RESISTANCE, BACTERIAL; HUMANS; JAPAN; PRODUCT SURVEILLANCE, POSTMARKETING; THIENAMYCINS; TIME FACTORS;

EID: 12144286756     PISSN: 03682781     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (32)

1. Jpn. J. Antibiotics 49: 175-193, 1996
2. Jpn. J. Antibiotics 52: 695-720, 1999
3. Jpn. J. Antibiotics 54: 145-170, 2001
4. Chemotherapy 40 (Suppl. 1): 222-237, 1992
5. Chemotherapy 40 (Suppl. 1): 123-131, 1992
6. SUNAGAWA, M.; H. MATSUMURA, Y. SUMITA, et al.: Structure features resulting in convulsive activity of carbapenem compounds: Effect of C-2 side chain. J. Antibiotics 48: 408-416, 1995
7. National Committee for Clinical Laboratory Standards: Performance standards for antimicrobial susceptibility testing; Twelfth informational supplement; M100-S12, 2002
8. National Committee for Clinical Laboratory Standards: Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; Approved standard-fifth edition; M7-A5, 2000
9. National Committee for Clinical Laboratory Standards: Methods for antimicrobial susceptibility testing of anaerobic bacteria; Approved standard-fifth edition; M11-A5, 2001
10. PERILLI, M.; E. DELL'AMICO, B. SEGATORE, et al.: Molecular characterization of extended-spectrum beta-lactamases produced by nosocomial isolates of Enterobacteriaceae from an Italian nationwide survey. J. Clin. Microbiol. 40: 611-614, 2002
11. YAGI, T.; H. KUROKAWA, K. SENDA, et al.: Nosocomial spread of cephem-resistant Escherichia coli strains carrying multiple Toho-1-like beta-lactamase genes. Antimicrob. Agents Chemother. 41: 2606-2611, 1997
12. STEWARD, C. D.; J. K. RASHEED, S. K. HUBERT, et al.: Characterization of clinical isolates of Klebsiella pneumoniae from 19 laboratories using the National Committee for Clinical Laboratory Standards extended-spectrum beta-lactamase detection methods. J. Clin. Microbiol. 39: 2864-2872. 2001
13. MA, L.; Y. ISHII, F. Y. CHANG, et al.: CTX-M-14, a plasmid-mediated CTX-M type extended-spectrum beta-lactamase isolated from Escherichia coli. Antimicrob. Agents Chemother. 46: 1985-1988, 2002
14. ISHII, Y.; J. ALBA, S. KIMURA, et al.: Rapid pulsed-field gel electrophoresis technique For determination of genetic diversity of Serratia marcescens. J. Infect. Chemother. 8(4): 368-370, 2002
15. TENOVER, F. C.; R. D. ARBEIT, R. V. GOERING, et al.: Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophorcsis: criteria for bacterial strain typing. J. Clin. Microbiol. 33: 2233-2239, 1995
16. Pharma Medica 20(5): 169-193. 2002
17. Jap. J. Antibiotics 55(6): 808-826. 2002
18. Chemothrapy 40 (Suppl. 1): 90-102. 1992
19. YAGI, T.; H. KUKOKAWA, N. SHIBATA, et al.: A preliminary survey of extended-spectrum β-lactamases (ESBLs) in clinical isolates of Klebsiella pneumoniae and Escherichia coli in Japan. FEMS Microbiol. Lett. 184: 53-56, 2000
20. Jpn. J. Antibiotics 53: 479-511, 2000
21. Jpn. J. Antibiotics 53: 387-408. 2000
22. SAITO, A.; T. INAMATSU, J. OKADA, et al.: Clinical breakpoints in pulmonary infections and sepsis: new antimicrobial agents and supplemental information for some agents already released. J. Infect. Chemother. 5: 223-226, 1999
23. KANAZAWA, K.; K. NOUDA, M. SUNAGAWA: Structure-activity relationships of carbapenem compounds to anti-Huemophilus influenzae activity and affinity for penicillin-binding proteins: Effect of 1-methyl group and C-2 side chain. J. Antibiotics 50: 162-168, 1997
24. TANAKA, M.; H. NAKAYAMA, H. TUNOE, et al.: A remarkable reduction in the susceptibility of Neisseria gonorrhoeae isolates to cephems and the selection of antibiotic regimens for the single-dose treatment of gonococcal infection in Japan. J. Infect. Chemother. 8: 81-86, 2002
25. BANDOH, K.; K. UENO, K. WATANABE, et al.: Susceptibility patterns and resistance to imipenem in Bacteroides fragilis group species in Japan. Clin. Infect. Dis. 16 (Suppl. 4): S382-S386, 1993